Switzerland-headquartered Oculis, a late-stage biopharmaceutical company focused on developing ophthalmic treatments, has appointed Webb Ding as global COO and General Manager, China. He takes up the role from February 1, 2022. Ding brings healthcare leadership experience, with a specific focus on the China market. He has more than 25 years of experience in general management,…
Home Healthcare Markets International People China: Oculis appoints Ding as global COO and General Manager, China